Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Jun;142(6):1714–1720.

Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.

H Tesch 1, A Günther 1, H Abts 1, M Jücker 1, S Klein 1, G R Krueger 1, V Diehl 1
PMCID: PMC1886973  PMID: 8506943

Abstract

Hodgkin and Reed-Sternberg cells, the putative malignant cells of Hodgkin's disease (HD), carry regularly the CD25 antigen that forms one chain of the interleukin-2 (IL-2) receptor (IL-2R alpha). To analyze the putative role of IL-2R expression in Hodgkin's disease, we have investigated the expression of both IL-2R alpha and IL-2R beta chains in HD-derived cell lines and in primary specimens from patients with HD. Expression of IL-2R alpha and IL-2R beta was detected in all HD-derived cell lines. In addition, soluble IL-2R alpha molecules were demonstrated in the supernatants of three of these cultured cell lines. In primary tissues, IL-2R alpha and IL-2R beta were seen in some but not all cases. Staining was detected in Hodgkin and Reed-Sternberg and in lymphoid cells. There was a remarkable difference in the pattern of expression, in that IL-2R alpha- but not IL-2R beta-positive cells from HD patients were clustered in frozen sections. We conclude from these data that IL-2R expression might be involved in the biology of HD.

Full text

PDF
1714

Images in this article

1718Figure 2
on p.1718
1718Figure 3
on p.1718

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arima N., Daitoku Y., Ohgaki S., Fukumori J., Tanaka H., Yamamoto Y., Fujimoto K., Onoue K. Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia. Blood. 1986 Sep;68(3):779–782. [PubMed] [Google Scholar]
  2. Diehl V., Kirchner H. H., Burrichter H., Stein H., Fonatsch C., Gerdes J., Schaadt M., Heit W., Uchanska-Ziegler B., Ziegler A. Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep. 1982 Apr;66(4):615–632. [PubMed] [Google Scholar]
  3. Falk M. H., Tesch H., Stein H., Diehl V., Jones D. B., Fonatsch C., Bornkamm G. W. Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease. Int J Cancer. 1987 Aug 15;40(2):262–269. doi: 10.1002/ijc.2910400223. [DOI] [PubMed] [Google Scholar]
  4. Faure G. C., Bene M. C., Bolle-Chanal M. H. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas. Eur J Haematol. 1987 Jan;38(1):26–30. doi: 10.1111/j.1600-0609.1987.tb01419.x. [DOI] [PubMed] [Google Scholar]
  5. Gause A., Roschansky V., Tschiersch A., Smith K., Hasenclever D., Schmits R., Diehl V., Pfreundschuh M. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann Oncol. 1991 Feb;2 (Suppl 2):43–47. doi: 10.1007/978-1-4899-7305-4_7. [DOI] [PubMed] [Google Scholar]
  6. Griesser H., Feller A., Lennert K., Minden M., Mak T. W. Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest. 1986 Nov;78(5):1179–1184. doi: 10.1172/JCI112700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hatakeyama M., Minamoto S., Uchiyama T., Hardy R. R., Yamada G., Taniguchi T. Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature. 1985 Dec 5;318(6045):467–470. doi: 10.1038/318467a0. [DOI] [PubMed] [Google Scholar]
  8. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4766–4770. doi: 10.1073/pnas.88.11.4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hsu S. M., Tseng C. K., Hsu P. L. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues. Am J Pathol. 1990 Apr;136(4):735–744. [PMC free article] [PubMed] [Google Scholar]
  10. Jücker M., Abts H., Li W., Schindler R., Merz H., Günther A., von Kalle C., Schaadt M., Diamantstein T., Feller A. C. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood. 1991 Jun 1;77(11):2413–2418. [PubMed] [Google Scholar]
  11. Laurent G., Al Saati T., Olive D., Laurent J. C., Poncelet P., Delsol G. Expression of Tac antigen in B cell lymphomas. Clin Exp Immunol. 1986 Aug;65(2):354–362. [PMC free article] [PubMed] [Google Scholar]
  12. Leonard W. J., Depper J. M., Crabtree G. R., Rudikoff S., Pumphrey J., Robb R. J., Krönke M., Svetlik P. B., Peffer N. J., Waldmann T. A. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature. 1984 Oct 18;311(5987):626–631. doi: 10.1038/311626a0. [DOI] [PubMed] [Google Scholar]
  13. Leonard W. J., Krönke M., Peffer N. J., Depper J. M., Greene W. C. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6281–6285. doi: 10.1073/pnas.82.18.6281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohbo K., Takeshita T., Asao H., Kurahayashi Y., Tada K., Mori H., Hatakeyama M., Taniguchi T., Sugamura K. Monoclonal antibodies defining distinct epitopes of the human IL-2 receptor beta chain and their differential effects on IL-2 responses. J Immunol Methods. 1991 Aug 28;142(1):61–72. doi: 10.1016/0022-1759(91)90293-o. [DOI] [PubMed] [Google Scholar]
  15. Poppema S. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol. 1989 Aug;135(2):351–357. [PMC free article] [PubMed] [Google Scholar]
  16. Robb R. J., Rusk C. M., Yodoi J., Greene W. C. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2002–2006. doi: 10.1073/pnas.84.7.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985 Oct;66(4):848–858. [PubMed] [Google Scholar]
  18. Strauchen J. A., Breakstone B. A. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases. Am J Pathol. 1987 Mar;126(3):506–512. [PMC free article] [PubMed] [Google Scholar]
  19. Tesch H., Herrmann T., Abts H., Diamantstein T., Diehl V. High affinity IL-2 receptors on a Hodgkin's derived cell line. Leuk Res. 1990;14(11-12):953–960. doi: 10.1016/0145-2126(90)90107-k. [DOI] [PubMed] [Google Scholar]
  20. Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4215–4218. doi: 10.1073/pnas.84.12.4215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Waldmann T. A., Goldman C. K., Bongiovanni K. F., Sharrow S. O., Davey M. P., Cease K. B., Greenberg S. J., Longo D. L. Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood. 1988 Nov;72(5):1805–1816. [PubMed] [Google Scholar]
  22. Weiss L. M., Strickler J. G., Hu E., Warnke R. A., Sklar J. Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol. 1986 Oct;17(10):1009–1014. doi: 10.1016/s0046-8177(86)80084-3. [DOI] [PubMed] [Google Scholar]
  23. Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol. 1987 Oct;129(1):86–91. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES